LaHaye, Stephanie
Fitch, James R.
Voytovich, Kyle J.
Herman, Adam C.
Kelly, Benjamin J.
Lammi, Grant E.
Arbesfeld, Jeremy A.
Wijeratne, Saranga
Franklin, Samuel J.
Schieffer, Kathleen M.
Bir, Natalie
McGrath, Sean D.
Miller, Anthony R.
Wetzel, Amy
Miller, Katherine E.
Bedrosian, Tracy A.
Leraas, Kristen
Varga, Elizabeth A.
Lee, Kristy
Gupta, Ajay
Setty, Bhuvana
Boué, Daniel R.
Leonard, Jeffrey R.
Finlay, Jonathan L.
Abdelbaki, Mohamed S.
Osorio, Diana S.
Koo, Selene C.
Koboldt, Daniel C.
Wagner, Alex H.
Eisfeld, Ann-Kathrin
Mrózek, Krzysztof
Magrini, Vincent
Cottrell, Catherine E.
Mardis, Elaine R.
Wilson, Richard K.
White, Peter http://orcid.org/0000-0002-5218-5903
Article History
Received: 11 March 2021
Accepted: 15 October 2021
First Online: 4 December 2021
Declarations
:
: This study was reviewed and approved by the Institutional Review Board (IRB) of The Research Institute at Nationwide Children’s Hospital. Written informed consent was obtained from the patients and/or parents for molecular genetic analysis, which included RNA-sequencing. These protocols allowed for return of results from research sequencing studies after confirmation in a CLIA-certified laboratory.
: Not applicable.
: <b>No Competing interests</b>: Stephanie LaHaye, James Fitch, Kyle Voytovich, Adam Herman, Benjamin Kelly, Grant Lammi, Jeremy Arbesfeld, Saranga Wijeratne, Kathleen Schieffer, Natalie Bir, Sean McGrath, Anthony Miller, Amy Wetzel, Katherine Miller, Tracy Bedrosian, Kristen Leraas, Elizabeth Varga, Ajay Gupta, Bhuvana Setty, Jeffrey Leonard, Jonathan Finlay, Mohamed Abdelbaki, Diana Osorio, Selene Koo, Daniel Koboldt, Alex Wagner, Ann-Kathrin Eisfeld, Krzysztof Mrozek, Vincent Magrini, Catherine Cottrell, Richard Wilson and Peter White.Elaine Mardis: Qiagen N.V., supervisory board member, honorarium and stock-based compensation.Daniel Boué: Illumina (ILMN) share holder.